Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study

被引:76
|
作者
Pulignano, Giovanni [1 ]
Del Sindaco, Donatella [2 ]
Di Lenarda, Andrea [3 ]
Tarantini, Luigi [4 ]
Cioffi, Giovanni [5 ]
Gregori, Dario [6 ]
Tinti, Maria Denitza [1 ]
Monzo, Luca [1 ]
Minardi, Giovanni [1 ]
机构
[1] San Camillo Hosp, Heart Failure Clin, Div Cardiol, Coronary Care Unit, Trieste, Italy
[2] Inst Care & Res Elderly INRCA, Heart Failure Unit, Div Cardiol, Trieste, Italy
[3] Cardiovasc Ctr & Univ, Trieste, Italy
[4] San Martino Hosp, Heart Failure Clin, Div Cardiol, Belluno, Italy
[5] Villa Bianca Hosp, Heart Failure Clin, Div Cardiol, Trento, Italy
[6] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy
关键词
cost-effectiveness; elderly; frailty; heart failure; management programs; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; CARE; MULTIDISCIPLINARY; PREVENT; INTERVENTION; CARDIOLOGY; MORTALITY; ADMISSION; OUTCOMES;
D O I
10.2459/JCM.0b013e328339d981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Disease management programs (DMP) improve outcomes in patients with heart failure. Because older heart failure patients represent a heterogeneous population, the aim of this study was to determine which patients benefit mostly from a DMP, by means of their frailty profile. Setting Heart failure outpatient clinic. Methods Consecutive (n = 173) patients aged more than 70 years were randomized to a multidisciplinary DMP (n = 86) or usual care (n = 87). A modified frailty score (range 1-6) was used as an index of global functional impairment. Results Mild to moderate frailty (frailty score = 2-3) was associated with significant improvements in outcomes (death and/or heart failure admission, heart failure admissions and all-cause admissions) in DMP patients vs. usual care. Even in more frail patients (frailty score = 4-6) a significant reduction in heart failure admissions was observed. By contrast, nonfrail patients (frailty score = 1) did not derive significant benefit. In the cost-effectiveness analysis, the mean savings per patient, stratified according to their frailty score, were (sic) -1003.31 for frailty score 1 (95% confidence interval -3717.00-1709.00), (sic) 1104.72 for frailty score 2 (-280.6-2491.00), (sic) 2635.42 for frailty score 3 (352.60-4917.00, P = 0.025) and (sic) 419.53 for frailty score 4-6 (-1909.00-2749.00). Intervention was therefore significantly cost saving in moderately frail, but not in nonfrail or severely frail patients. Thus, DMP was dominant (i.e. both less costly and more effective than usual care) in moderately frail patients. At sensitivity analysis, DMP remained dominant even to changes in cost of intervention and hospitalizations. Conclusion This suggests that an intensive, hospital-based DMP appears to be more effective in older patients with mild-to-moderate levels of frailty. Thus, a multidimensional assessment of frailty seems to be a useful tool for appropriate selection of model of care. J Cardiovasc Med 11: 739-747 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:739 / 747
页数:9
相关论文
共 50 条
  • [31] Heart Failure Costs, Minority Populations, and Outcomes Targeting Health Status, Not Utilization, to Bend the Cost-Effectiveness Curve
    Konstam, Marvin A.
    JACC-HEART FAILURE, 2018, 6 (05) : 398 - 400
  • [32] Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction
    Liang, Lin
    Wu, David Bin-Chia
    Aziz, Mohamed Ismail Abdul
    Wong, Raymond
    Sim, David
    Leong, Kui Toh Gerard
    Wei, Yong Quek
    Tan, Doreen
    Ng, Kwong
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 174 - 181
  • [33] Assessment of the Clinical Outcomes and Cost-effectiveness of the Management of Systolic Heart Failure in Chinese Patients Using a Home-based Intervention
    Chen, Y-H
    Ho, Y-L
    Huang, H-C
    Wu, H-W
    Lee, C-Y
    Hsu, T-P
    Cheng, C-L
    Chen, M-F
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 242 - 252
  • [34] Comparison of Rate Control versus Rhythm Control for Management of Atrial Fibrillation in Patients with Coexisting Heart Failure: A Cost-Effectiveness Analysis
    Perez, Alexandra
    Touchette, Daniel R.
    DiDomenico, Roberti J.
    Stamos, Thomas D.
    Walton, Surrey M.
    PHARMACOTHERAPY, 2011, 31 (06): : 552 - 565
  • [35] Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models
    De Almeida, Fernando Albuquerque
    Al, Maiwenn
    Koymans, Ron
    Caliskan, Kadir
    Kerstens, Ankie
    Severens, Johan L.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (02) : 161 - 175
  • [36] Evaluation of the effectiveness and cost-effectiveness of the chronic disease co-care (CDCC) Pilot Scheme: a study protocol
    Mak, Ivy L.
    Liu, Kiki S. N.
    Wong, Zoey C. T.
    Xu, Vivian Y. H.
    Yu, Esther Y. T.
    Ha, Tony K. H.
    Wong, William C. W.
    Tse, Emily T. Y.
    Chan, Linda
    Ng, Amy P. P.
    Choi, Edmond P. H.
    Roland, Martin
    Bishai, David
    Lam, Cindy L. K.
    Wan, Eric Y. F.
    BMC PRIMARY CARE, 2025, 26 (01):
  • [37] Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England
    Kolovos, Spyros
    Bellanca, Leana
    Groyer, Harinala
    Rosano, Giuseppe
    Gaultney, Jennifer
    Linden, Stephan
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (10) : 758 - 764
  • [38] Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction
    Parizo, Justin T.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    Khush, Kiran K.
    Spertus, John A.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA CARDIOLOGY, 2021, 6 (08) : 926 - 935
  • [39] Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study
    Maru, Shoko
    Byrnes, Joshua M.
    Carrington, Melinda J.
    Stewart, Simon
    Scuffham, Paul A.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 318 - 327
  • [40] Cost-effectiveness of the treatment of heart failure with ramipril: a Spanish analysis of the AIRE study
    Hart, WM
    Rubio-Terres, C
    Pajuelo, F
    Juanatey, JRG
    EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (04) : 553 - 558